IBC 293

IBC 293 is an experimental drug which acts as a potent and selective agonist for the Hydroxycarboxylic acid receptor 3 (GPR109B), with good selectivity over the closely related HCA2/GPR109A receptor. It is used for studying the function of this receptor, and has been shown to activate neutrophils, demonstrating a role for HCA3 in immune system function.^[1][2][3]

IBC 293

Identifiers
IUPAC name 1-propan-2-ylbenzotriazole-5-carboxylic acid
CAS Number	306935-41-1
PubChem CID	2736690
IUPHAR/BPS	1597
ChemSpider	2018348
ChEBI	CHEBI:92275
ChEMBL	ChEMBL381638
CompTox Dashboard (EPA)	DTXSID70371532
Chemical and physical data
Formula	C10H11N3O2
Molar mass	205.217 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(C)N1C2=C(C=C(C=C2)C(=O)O)N=N1
InChI InChI=1S/C10H11N3O2/c1-6(2)13-9-4-3-7(10(14)15)5-8(9)11-12-13/h3-6H,1-2H3,(H,14,15) Key:RUTVRAJKELSHCC-UHFFFAOYSA-N